Table 2.
Safety profiles after T-cell therapy.
Adverse events | n = 30 (%) |
---|---|
Grade 1 | 10 (33.3%) |
Fatigue | 1 (3.3%) |
Dry cough | 1 (3.3%) |
Fever | 3 (10%) |
Chills | 1 (3.3%) |
Chest pain | 1 (3.3%) |
Sore throat | 1 (3.3%) |
Hyperbilirubinemia | 1 (3.3%) |
Altered hearing ability | 1 (3.3%) |
Grade 2 | 6 (20%) |
Fatigue | 2 (6.7%) |
Fever | 1 (3.3%) |
Dyspnea | 1 (3.3%) |
Headache | 1 (3.3%) |
Vomiting | 1 (3.3%) |
Grade 3 | 2 (6.7%) |
Lung abscess | 2 (6.7%) |